- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
It's not all ChatGPT — 13 other generative AI technologies to watch
A new breed of artificial intelligence startups are moving from basic automation into new areas of creativity. Here are some of the key names and their corporate investors.
Jan 18, 2023What Microsoft and OpenAI learned from Sequoia and YouTube
Tech's greatest deal had been YouTube by Sequoia but the venture model has evolved with founder ambitions
Jan 17, 2023Supply chain is (still) blockchain’s killer app — it just needs to…
The failure of Tradelens has rocked faith in supply chain blockchain, but used correctly, the technology can bring trust back to transactions.
Jan 15, 2023The Big Deal: WM parks in a cut-price spot
WM Motor is executing a reverse merger at a hefty cut from its 2021 valuation, showing the big risks involved with investing in China's saturated electric vehicle sector.
Jan 13, 2023Sanofi swells venture fund to $750m
Sanofi's strategic investment arm received a top up from its pharmceutical parent in a week when it led an $80m round for its latest portfolio company.
Jan 12, 2023This is what consumer sector investors plan to back in 2023
Synthetic biology, healthier options, sustainability and digitalisation are big themes for the beauty and food industries this year.
Jan 12, 2023Gareth Burns joins BP Ventures
The former head of Equinor Ventures joins bp ventures at a time of transition at the fund.
Jan 11, 2023Is 2023 the boom year for CVC?
Several new corporate venture units have launched in the past few weeks, showing that big business is still committed to startup investing.
Jan 10, 2023The silent pandemic: how Microplate Dx is fighting antimicrobial resistance
Today, 1.3 million people die each year because of antimicrobial resistance, a figure that could increase to 10 million by 2050 — Strathclyde’s Microplate Dx hopes to prevent that.
Jan 9, 2023What next for healthcare CVC in 2023?
What's going to happen to healthcare startup funding this year? Will the IPO market recover? And what kinds of technologies are on the up? We asked some leading CVCs for their view.
Jan 8, 2023The Big Deal: Metagenomi shows that gene therapies continue to pull in…
The $275m round, the largest series B for three months, featured several pharmaceutical companies and is part of a thriving environment for gene therapy startups.
Jan 6, 2023“Talk to me, drones” – Meet the company designing the AI wingman
With a fresh cash injection from Raytheon’s RTX Ventures, EpiSci is creating autonomous software to enhance warfighters’ capabilities.
Jan 6, 2023Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


